Skip to content

Comparative Trial of Two Ayuredic Treatment in Ekakustha(Psoriasis)

Clinical evaluation of two Ayurveda treatment regimes in Ekakustha

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/02/023196
Enrollment
40
Registered
2020-02-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L989- Disorder of the skin and subcutaneous tissue, unspecified

Interventions

Intervention1: Vaman With Krutvedhan Churan: Vaman With Krutvedhan By Oral Route According To Agni Followed By Virechan With Abhyadi Modak And Panchtikta Panchprasritiki Basti Control Intervention1: V

Sponsors

Ch Brahm Praskash Ayurved Charak Sansthan
Lead Sponsor
Ch Brahm Praskash Ayurved Charak Sansthan
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient showing sign and symptoms of Ekakushtha in Charak Samhita and Psoriasis Diagnosis on the basis of Modern classics. 2. Patient within the age group of 20-50 years. 3. Disease duration >1 year. 4. Patients not taking corticosteroids since last 3 months.

Exclusion criteria

Exclusion criteria: 1.Age below the age is 20 year and above the age 50yr. 2.Patients of hypertension, tuberculosis, carcinoma, other lifeâ??threatening and complicated disease and major systemic illnesses. 3.Severe condition of Psoriasis like Psoriatic arthritis. 4.Disease duration 5.Patients on treatment with any conventional oral medicines for last one month. 6.Pregnant & lactating mother.

Design outcomes

Primary

MeasureTime frame
Pasi scoreTimepoint: after vaman, after virechan,after basti, on 60th day

Secondary

MeasureTime frame
symptoms of ekakusthaTimepoint: after vaman, after virechan,after basti, on 60th day

Countries

India

Contacts

Public ContactRAVINDRA KUMAR

CH. BRAHM PRAKASH AYURVED CHARAK SANSTHAN

ARUN24@HOTMAIL.COM9999155377

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026